Apr 8 (Reuters)-
Cosmos Pharmaceutical Corp.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Feb 28, 2019 Feb 28, 2018 May 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 450.49 410.77 610.00
(+9.7 pct) (+10.8 pct) (+9.3 pct)
Operating 18.03 15.78 23.00
(+14.2 pct) (-9.2 pct) (+1.1 pct)
Recurring 19.69 17.65 25.50
(+11.5 pct) (-7.6 pct) (+1.0 pct)
Net 13.21 11.87 17.65
(+11.2 pct) (-5.6 pct) (+0.1 pct)
EPS 667.09 yen 599.73 yen 891.43 yen
Ann Div 90.00 yen 90.00 yen
-Q2 div 45.00 yen 45.00 yen
-Q4 div 45.00 yen 45.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T